For example, comparing Mounjaro vs Wegovy shows both medications share similar side effect profiles, though individual responses can vary
GLP-1 (glucagon-like peptide-1) receptor agonists are prescribed for type 2 diabetes management and, increasingly, for weight management as recommended in NICE guidance (NG28, TA875, TA664)
Dokken BB, Hilwig WR, Teachey MK, Panchal RA, Hubner K, Allen D, et al
The requirements are clear for diagnosis code entry, and approval feedback is immediate, allowing for quick resolution of any issues
Most protocols start at 0.25mg weekly for the first four weeks, then increase to 0.5mg, then 1mg, and potentially higher depending on response and tolerance
You start treatment and continue your life without interruption